Weik Capital Management Sanofi Transaction History

Weik Capital Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 11, 2018	SELL	$38.98 - $45.76 $417,982 - $490,684	-10,723 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$47.04 - $50.34 $227,109 - $243,041	4,828 Added 81.9%	10,723 $534,000
Q2 2017 Aug 14, 2017	BUY	N/A	5,895	5,895 $282,000

820

274M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Weik Capital Management, based on Form 13F filings with the SEC.

Stay updated on Weik Capital Management with notifications on news.